Peptineo Inks Exclusive Option for Drug Delivery Technologies from Lawrence Berkeley Labs

Peptineo, a privately held biotechnology company, announced today that the company has inked an exclusive option for a broad set of nanotechnology patents in the area of drug delivery from Lawrence Berkeley National Laboratory. Under this agreement, Peptineo will work to commercialize drug delivery technologies developed in the laboratories of Dr. Carolyn Bertozzi and Dr. Jean M.J. Fréchet. “Securing an [PR.com]
PR.com Press Releases: Medical & Health: Pharmaceuticals News

Pharmaceutical Stocks

[stock-ticker]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us